Examkin

Question

Difficulty: MediumRheumatology and Immunology

A 28-year-old woman comes to the clinic for evaluation of chronic fatigue, poor sleep, and diffuse muscle aches over the past 4 months. She describes the pain as "aching all over" and notes that she often wakes up feeling unrefreshed. She has no history of joint swelling, facial rashes, oral ulcers, or fever. Her medical history is notable for atypical depression, for which she currently takes phenelzine. Physical examination reveals normal range of motion in all joints with no effusions, erythema, or synovitis. However, there is symmetric point tenderness to palpation over the neck, shoulders, and greater trochanters.

Because she was worried about having systemic lupus erythematosus (SLE), she recently obtained laboratory tests at an independent clinic. The results are as follows:

Laboratory TestResultReference Range
Hemoglobin13.2 g/dL12.0–15.5 g/dL
Leukocyte count7,200/mm³4,500–11,000/mm³
Antinuclear antibody (ANA)1:40<1:40
Thyroid-stimulating hormone (TSH)1.8 µU/mL0.4–4.0 µU/mL
Free thyroxine (T4)1.2 ng/dL0.9–2.4 ng/dL
Erythrocyte sedimentation rate (ESR)10 mm/hr0–20 mm/hr

Based on the patient's clinical presentation and laboratory findings, which of the following is the most appropriate next step in management?

  1. Recommend a graded aerobic exercise programAnswer
  2. B
    Order anti-double-stranded DNA and anti-Smith antibodies
  3. C
    Prescribe oral duloxetine
  4. D
    Initiate levothyroxine therapy
  5. E
    Administer an empirical course of broad-spectrum antibiotics

Answer

The correct answer is to recommend a graded aerobic exercise program.
The correct answer involves recommending a graded aerobic exercise program. This patient's presentation of widespread musculoskeletal pain, chronic fatigue, unrefreshed sleep, and point tenderness over characteristic soft-tissue areas (neck, shoulders, hips) without joint effusions is highly consistent with fibromyalgia. A low-titer antinuclear antibody (ANA) of 1:40 is present in up to 20% of the healthy female population and is a common incidental finding. Without specific clinical features of systemic lupus erythematosus (SLE) such as malar rash, inflammatory arthritis, pleuritis, or cytopenias, the positive predictive value of a low-titer ANA is extremely low. Therefore, the ANA finding represents a false positive for SLE and requires no further rheumatologic workup. Initial management of fibromyalgia relies on non-pharmacologic measures, notably patient education, sleep hygiene optimization, and a supervised graded aerobic exercise program. While pharmacologic options like SNRIs (e.g., duloxetine) or TCAs (e.g., amitriptyline) are available, non-pharmacologic interventions are the safest and most appropriate first step, particularly given her complex psychiatric medication regimen.

Step-by-Step Solution

1
Analyze the clinical presentation.
The patient presents with chronic widespread musculoskeletal pain, profound fatigue, unrefreshed sleep, and specific tender points without any signs of joint inflammation. This presentation meets the classic criteria for fibromyalgia.
Establishing the primary clinical syndrome is necessary before interpreting patient-ordered diagnostic tests.
2
Interpret the laboratory findings.
The low-titer ANA (1:40) in the absence of SLE symptoms (no malar rash, arthritis, or cytopenias) is an incidental false positive. TSH and ESR are strictly normal, ruling out hypothyroidism and systemic inflammation.
Ruling out inflammatory or endocrine mimics of fibromyalgia is critical to prevent misdiagnosis.
3
Evaluate management options while considering current medications.
Initial fibromyalgia management is non-pharmacologic, prioritizing a graded aerobic exercise program. Pharmacologic agents like SNRIs (duloxetine) are contraindicated due to her concurrent phenelzine (MAOI) use.
To provide evidence-based symptom relief while avoiding potentially fatal drug interactions.

Key Concept

Diagnosis and initial non-pharmacologic management of fibromyalgia, and the interpretation of low-titer positive ANA in healthy populations.
Estimated Time:1m 30s
Rate this question

Topics

Rheumatology and Immunology

More questions from this topic